Literature DB >> 27740906

The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort.

Charles S White1, Ekta Dharaiya1, Erin Campbell1, Lilla Boroczky1.   

Abstract

Purpose To assess the likelihood of malignancy among a subset of nodules in the National Lung Screening Trial (NLST) by using a risk calculator based on nodule and patient characteristics. Materials and Methods All authors received approval for use of NLST data. An institutional review board exemption and a waiver for informed consent were granted to the author with an academic appointment. Nodule characteristics and patient attributes with regard to benign and malignant nodules in the NLST were applied to a nodule risk calculator from a group in Vancouver, Canada. Patient populations and their nodule characteristics were compared between the NLST and Vancouver cohorts. Multiple thresholds were tested to distinguish benign nodules from malignant nodules. An optimized threshold value was used to determine positive and negative predictive values, and a full logistic regression model was applied to the NLST data set. Results Sufficient data were available for 4431 nodules (4315 benign nodules and 116 malignant nodules) from the NLST data set. The NLST and Vancouver data sets differed in that the former included fewer nodules per study, fewer nonsolid nodules, and more nodule spiculation and emphysema. A composite risk score threshold of 10% was determined to be optimal, demonstrating sensitivity, specificity, positive predictive value, and negative predictive value of 85.3%, 93.9%, 27.4%, and 99.6%, respectively. The receiver operating characteristic curve for the full regression model applied to the NLST database demonstrated an area under the receiver operating characteristic curve of 0.963 (95% confidence interval: 0.945, 0.974). Conclusion Application of an NLST data subset to the Vancouver risk calculator yielded a high discriminant value, which supports the use of a risk calculator method as a valuable approach to distinguish between benign and malignant nodules. © RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2016        PMID: 27740906     DOI: 10.1148/radiol.2016152627

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study.

Authors:  David S Gierada; William C Black; Caroline Chiles; Paul F Pinsky; David F Yankelevitz
Journal:  Radiol Imaging Cancer       Date:  2020-03-27

2.  Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort.

Authors:  Abraham Kessler; Robert Peng; Edward Mardakhaev; Linda B Haramati; Charles S White
Journal:  Radiol Imaging Cancer       Date:  2020-03-27

Review 3.  Implementation planning for lung cancer screening in China.

Authors:  Yue I Cheng; Michael P A Davies; Dan Liu; Weimin Li; John K Field
Journal:  Precis Clin Med       Date:  2019-03-14

4.  A new classifier constructed with platelet features for malignant and benign pulmonary nodules based on prospective real-world data.

Authors:  Ruiling Zu; Lin Wu; Rong Zhou; Xiaoxia Wen; Bangrong Cao; Shan Liu; Guishu Yang; Ping Leng; Yan Li; Li Zhang; Xiaoyu Song; Yao Deng; Kaijiong Zhang; Chang Liu; Yuping Li; Jian Huang; Dongsheng Wang; Guiquan Zhu; Huaichao Luo
Journal:  J Cancer       Date:  2022-05-09       Impact factor: 4.478

5.  Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions.

Authors:  Lori C Sakoda; Louise M Henderson; Tanner J Caverly; Karen J Wernli; Hormuzd A Katki
Journal:  Curr Epidemiol Rep       Date:  2017-10-24

6.  Developing an understanding of artificial intelligence lung nodule risk prediction using insights from the Brock model.

Authors:  Madhurima R Chetan; Nicholas Dowson; Noah Waterfield Price; Sarim Ather; Angus Nicolson; Fergus V Gleeson
Journal:  Eur Radiol       Date:  2022-03-03       Impact factor: 7.034

7.  Validation of prediction models for risk stratification of incidentally detected pulmonary subsolid nodules: a retrospective cohort study in a Korean tertiary medical centre.

Authors:  Hyungjin Kim; Chang Min Park; Sunkyung Jeon; Jong Hyuk Lee; Su Yeon Ahn; Roh-Eul Yoo; Hyun-Ju Lim; Juil Park; Woo Hyeon Lim; Eui Jin Hwang; Sang Min Lee; Jin Mo Goo
Journal:  BMJ Open       Date:  2018-05-24       Impact factor: 2.692

8.  Nomogram For The Prediction Of Malignancy In Small (8-20 mm) Indeterminate Solid Solitary Pulmonary Nodules In Chinese Populations.

Authors:  Xiao-Bo Chen; Rui-Ying Yan; Ke Zhao; Da-Fu Zhang; Ya-Jun Li; Lin Wu; Xing-Xiang Dong; Ying Chen; De-Pei Gao; Ying-Ying Ding; Xi-Cai Wang; Zhen-Hui Li
Journal:  Cancer Manag Res       Date:  2019-11-06       Impact factor: 3.989

Review 9.  Implications of the updated Lung CT Screening Reporting and Data System (Lung-RADS version 1.1) for lung cancer screening.

Authors:  Spencer C Dyer; Brian J Bartholmai; Chi Wan Koo
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.